Drexel University - Comprehensive, integrated academics enhanced by co-operative education, technology, and research opportunities. | Drexel University
Drexel University
Search events. View events.

All Categories

Click for help in using calendar displays. Print the contents of the current screen.
Display Format: 
Event Details
Notify me if this event changes.Add this event to my personal calendar.
Go Back
Neurosciences Grand Rounds
Start Date: 9/8/2017Start Time: 8:00 AM
End Date: 9/8/2017End Time: 9:00 AM

Event Description

Pinpointing the Progression of Multiple Sclerosis: Differentiation, Evaluation and Treatment Updates

Hosted By
Drexel Neurosciences Institute

Presented By
Daniel Ontaneda, MD, MS, Departments of Medicine and Neurology, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University

Learning Objectives

  • Discuss the differential findings regarding the pathophysiology of primary progressive multiple sclerosis (PPMS)
  • Identify specific aspects of evaluation, including objective tests and measures that can help to pinpoint PPMS and quantify its progression
  • Discuss the evaluation of data on pharmacologic treatments that may emerge with a role in treating patients with PPMS

Target Audience
Faculty, physicians, fellows, residents, medical students, PAs, CRNPs, RNs, all medical specialties

Continuing Medical Education Credits
Drexel University College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement: The Drexel University College of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

AOA: This program is eligible for 1 credits in Category 2A of the American Osteopathic Association.

Speakers at continuing medical education activities are required to disclose to the audience, any relevant commercial interest (which is any entity producing, marketing, reselling or distributing health care goods or services consumed by, or used on, patients). Any conflicts of interest must be resolved prior to the presentation and announced to the audience.

Dr. Ontaneda has disclosed that he is a consultant with Biogen Idec and a contracted researcher with Novartis, Genentech and Genzyme. He will resolve his conflicts of interest by supporting his presentation and clinical recommendations with the “best available evidence” from the medical literature.

Contact Information:
Name: Kirsten Erwin
Email: kle27@drexel.edu
New College Building
Geary Auditorium A
245 North 15th Street
  • Graduate Students
  • Faculty
  • Staff
  • Alumni
  • Medical Residents/Fellows
  • Special Features:
  • CEU Available

  • Display Month:

    Advanced Search (New Search)
    Date Range:
    Time Range:

    Special Features: 

    Select item(s) to Search

    Select item(s) to Search
    Select item(s) to Search
    Select item(s) to Search